Ying-Bin Liu (Yingbin Liu)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Venues

BMJ open

RSC advances

Cancer science

Cellular & molecular biology letters

This page only lists publications with an associated author ORCID identifier.

Publications

Jiatong Li, Ao Gu, Xiao-Mei Nong, Shuyang Zhai, Zhu-Ying Yue, Meng-Yao Li, Ying-Bin Liu
Six-membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications. Chemical record (New York, N.Y.) (2023)
Mao Yang, Yuhao Zhao, Yongsheng Li, Xuya Cui, Fatao Liu, Wenguang Wu, Xu-An Wang, Maolan Li, Yun Liu, Ying-Bin Liu
Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. BMJ open 13 (2) (2023)
Dong Wei, Han-Yu Lu, Han-Zhe Miao, Chen-Guo Feng, Guo-Qiang Lin, Ying-Bin Liu
Pd-catalyzed intermolecular consecutive double Heck reaction "on water" under air: facile synthesis of substituted indenes. RSC advances 13 (28) (2023)
Dong Wei, Han-Yu Lu, Han-Zhe Miao, Chen-Guo Feng, Guo-Qiang Lin, Ying-Bin Liu
Pd-catalyzed intermolecular consecutive double Heck reaction "on water" under air: facile synthesis of substituted indenes. RSC advances 13 (28) (2023)
Mao Yang, Yuhao Zhao, Yongsheng Li, Xuya Cui, Fatao Liu, Wenguang Wu, Xu-An Wang, Maolan Li, Yun Liu, Ying-Bin Liu
Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. BMJ open 13 (2) (2023)
Dong Wei, Han-Yu Lu, Han-Zhe Miao, Chen-Guo Feng, Guo-Qiang Lin, Ying-Bin Liu
Pd-catalyzed intermolecular consecutive double Heck reaction "on water" under air: facile synthesis of substituted indenes. RSC advances 13 (28) (2023)
Mao Yang, Yuhao Zhao, Yongsheng Li, Xuya Cui, Fatao Liu, Wenguang Wu, Xu-An Wang, Maolan Li, Yun Liu, Ying-Bin Liu
Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. BMJ open 13 (2) (2023)
Zi-Yao Jia, Yi-Di Zhu, Xiang-Song Wu, Jing-Xiao Yang, Wen-Guang Wu, Xu-An Wang, Min He, Hui Wang, Lin-Hua Yang, Jie Zhang, Xue-Chuan Li, Lu Zou, Huai-Feng Li, Fei Zhang, Run-Fa Bao, Xu-Ya Cui, Xiao-Ling Song, Wei Chen, Wei Gong, Mao-Lan Li, Ying-Bin Liu
Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer. Cancer medicine (2023)
Mao Yang, Yuhao Zhao, Yongsheng Li, Xuya Cui, Fatao Liu, Wenguang Wu, Xu-An Wang, Maolan Li, Yun Liu, Ying-Bin Liu
Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. BMJ open 13 (2) (2023)
Mao Yang, Yuhao Zhao, Yongsheng Li, Xuya Cui, Fatao Liu, Wenguang Wu, Xu-An Wang, Maolan Li, Yun Liu, Ying-Bin Liu
Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. BMJ open 13 (2) (2023)
Yang Li, Bo Yang, Huijie Miao, Liguo Liu, Ziyi Wang, Chengkai Jiang, Yang Yang, Shimei Qiu, Xuechuan Li, Yajun Geng, Yijian Zhang, Ying-Bin Liu
Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma. Hepatology (Baltimore, Md.) (2023)
Mao Yang, Yuhao Zhao, Yongsheng Li, Xuya Cui, Fatao Liu, Wenguang Wu, Xu-An Wang, Maolan Li, Yun Liu, Ying-Bin Liu
Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. BMJ open 13 (2) (2023)
Lu Zou, Yang Yang, Biyu Zhou, Weijian Li, Ke Liu, Guoqiang Li, Huijie Miao, Xiaoling Song, Jiahua Yang, Yajun Geng, Maolan Li, Runfa Bao, Ying-Bin Liu
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L. Cellular & molecular biology letters 27 (1) (2022)
Huijie Miao, Yajun Geng, Yang Li, Shijie Tang, Feiling Feng, Weijian Li, Yongsheng Li, Liguo Liu, Rui Zhang, Shimei Qiu, Ying Wu, Zeyu Wang, Ziyi Wang, Ziyu Shao, Ke Liu, Lu Zou, Mao Yang, Yuhao Zhao, Chen Chen, Zhizhen Li, Dadong Zhang, Peng Peng, Xiaoyan Qiang, Frank Wu, Yongning He, Luonan Chen, Dongxi Xiang, Xiaoqing Jiang, Maolan Li, Yun Liu, Ying-Bin Liu
Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway. Cellular oncology (Dordrecht) 45 (4) (2022)
Yang Li, Ruiyan Yuan, Tai Ren, Bo Yang, Huijie Miao, Liguo Liu, Yongsheng Li, Chen Cai, Yang Yang, Yunping Hu, Chengkai Jiang, Qindie Xu, Yijian Zhang, Ying-Bin Liu
Role of Sciellin in gallbladder cancer proliferation and formation of neutrophil extracellular traps. Cell death & disease 12 (1) (2021)
Xiaofei Zhang, Tiebo Mao, Bei Zhang, Haiyan Xu, Jiujie Cui, Feng Jiao, Dongqin Chen, Yu Wang, Jiong Hu, Qing Xia, Shumin Li, Ming Yue, Jingyu Ma, Jiayu Yao, Yongchao Wang, Xiao Zhang, Shiqing Chen, Yuezong Bai, Yuexiang Wang, Xuebin Zhang, Qiang Liu, Yongwei Sun, Deliang Fu, Ying-Bin Liu, Lei Xiong, Liwei Wang
Characterization of DNA damage response deficiency in pancreatic cancer patients from China. Cancer communications (London, England) (2021)
Tai Ren, Yongsheng Li, Xi Zhang, Yajun Geng, Ziyu Shao, Maolan Li, Xiangsong Wu, Xu-An Wang, Fatao Liu, Wenguang Wu, Yijun Shu, Runfa Bao, Wei Gong, Ping Dong, Xueyi Dang, Chang Liu, Changjun Liu, Bei Sun, Jun Liu, Lin Wang, Defei Hong, Renyi Qin, Xiaoqing Jiang, Xuewen Zhang, Junmin Xu, Jianguang Jia, Bo Yang, Bing Li, Chaoliu Dai, Jingyu Cao, Hong Cao, Feng Tao, Zaiyang Zhang, Yi Wang, Huihan Jin, Hongyu Cai, Zhewei Fei, Jianfeng Gu, Wei Han, Xuedong Feng, Lu Fang, Linhui Zheng, Chunfu Zhu, Kunhua Wang, Xueli Zhang, Xiaoyong Li, Chong Jin, Yeben Qian, Yunfu Cui, Yuzhen Xu, Xiang Wang, Houbao Liu, Yawei Hua, Chao Liu, Jihui Hao, Chuanlei Wang, Qiyun Li, Xun Li, Jiansheng Liu, Mingzhang Li, Yudong Qiu, Buqiang Wu, Jinfang Zheng, Xiaoliang Chen, Haihong Zhu, Kejun Hua, Maolin Yan, Peng Wang, Hong Zang, Xiaoming Ma, Jian Hong, Ying-Bin Liu
Protocol for a gallbladder cancer registry study in China: the Chinese Research Group of Gallbladder Cancer (CRGGC) study. BMJ open 11 (2) (2021)
Xiaoling Song, Xu'an Wang, Yunping Hu, Huaifeng Li, Tai Ren, Yongsheng Li, Liguo Liu, Lin Li, Xuechuan Li, Ziyi Wang, Wen Huang, Runfa Bao, Yijian Zhang, Maolan Li, Xuefeng Wang, Feng Liu, Jun Gu, Linhui Zheng, Wenguang Wu, Ying-Bin Liu
A metagenomic study of biliary microbiome change along the cholecystitis-carcinoma sequence. Clinical and translational medicine 10 (2) (2020)
Xiaoling Song, Maolan Li, Wenguang Wu, Wei Dang, Yuan Gao, Rui Bian, Runfa Bao, Yunping Hu, Defei Hong, Jun Gu, Ying-Bin Liu
Regulation of BMP2K in AP2M1-mediated EGFR internalization during the development of gallbladder cancer. Signal transduction and targeted therapy 5 (1) (2020)
Yuan Gao, Zheng Wang, Yidi Zhu, Qin Zhu, Yang Yang, Yunpeng Jin, Fei Zhang, Lin Jiang, Yuanyuan Ye, Huaifeng Li, Yichi Zhang, Haibin Liang, Shanshan Xiang, Huijie Miao, Ying-Bin Liu, Yajuan Hao
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma. Cancer science 110 (11) (2019)
Huaifeng Li, Yunpeng Jin, Yunping Hu, Lin Jiang, Fatao Liu, Yijian Zhang, Yajuan Hao, Shili Chen, Xiangsong Wu, Ying-Bin Liu
The PLGF/c-MYC/miR-19a axis promotes metastasis and stemness in gallbladder cancer. Cancer science 109 (5) (2018)

Ying-Bin Liu.css-eqlu8i{font-size:small;padding-left:4px;} (Yingbin Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Ying-Bin Liu (Yingbin Liu)